BenevolentAl Therapeutics Pipeline and Triage slide image

BenevolentAl Therapeutics Pipeline and Triage

Some of our recent publications Knowledge Wiatrak et al. (202`1) Zero-Shot Metric Learning Entity Linking submitted to Transactions of ACL. Shah and Fauqueur (2020) Learning Informative Representations of Biomedical Relations with Latent Variable Models, in EMNLP 2020, SustaiNLP Workshop. Wiatrak and Iso-Sipila (2020) Simple Hierarchical Multi-Task End-to-End Entity Linking for Biomedical Text in EMNLP 2020, LOUHI Workshop. Target Identification • Dunbar et al. (2021) Transforming drug target identification in CKD: a multidisciplinary artificial intelligence-based approach submitted to Nature Comms. Paliwal et al. (2020) Preclinical validation of therapeutic targets predicted by tensor factorization on heterogeneous graphs in Nature Scientific Reports. Myszczynska et al. (2020) Applications of machine learning to diagnosis and treatment of neurodegenerative diseases, in Nature Reviews Neurology. Precision Medicine Foster et al. (2021) Contrastive Mixture of Posteriors for Counterfactual Inference, Data Integration and Fairness submitted to NeurIPS 2021. Sim et al. (2021) Directed Graph Embeddings in Pseudo-Riemannian Manifolds in ICML 2021. ⚫. Schneider and Tomlinson (2020) Auxiliary task evaluations to learn meaningful representations from electronic health records in NeurIPS 2020, Workshop on Learning Meaningful Representations of Life. Chemistry Fabian et al. (2020) Molecular representation learning with language models and domain-relevant auxiliary tasks, in NeurIPS 2020, Machine Learning for Molecules Workshop. Simonovsky and Meyers (2020) DeeplyTough: Learning Structural Comparison of Protein Binding Sites, in Journal of Chemical Information and Modeling. Brown (2020) Artificial Intelligence in Drug Discovery, in Royal Society of Chemistry Richardson et al. (2020) Baricitinib as potential treatment for 2019-nCoV acute respiratory disease, in The Lancet Stebbing et al. (2020) COVID-19: combining antiviral and anti-inflammatory treatments, in The Lancet Infectious Diseases Benevolent 34 Al
View entire presentation